Comparative Spillover Dynamics of Avian Influenza in Endemic Countries
Project Number1R56TW009502-01
Contact PI/Project LeaderDASZAK, PETER
Awardee OrganizationECOHEALTH ALLIANCE, INC.
Description
Abstract Text
Avian influenza A/H5N1 was first identified in the late 1990s. To date, it has caused outbreaks in poultry or wild birds in 58 countries resulting In at least 571 human cases, and 335 human deaths, and more than $10 billion in economic losses, largely due to culling of poultry. Despite radical, often draconian, control efforts. H5N1 persists across many parts of the Old World and continues to threaten global health and development. In this proposed work we will use a combination of three different modeling approaches, collection of field surveillance data on domestic poultry and wild birds and a contact survey in /VH5N1 endemic countries to investigate what factors lead to the endemic persistence of A/H5N1. We will integrate dynamical, spatial and network models to develop a predictive capacity for the spillover of H5N1 from poultry to people. We have assembled a multidisciplinary team of leading disease ecologists, leveraging many years of experience in three H5N1 endemic (Bangladesh, China, and Egypt) and one control country (Cameroon, where H5N1 is not endemic). We will collect data on wild waterfowl migration, poultry farm size, market dynamics and human contact networks with these sources of infection. We will collect samples and examine data on viral incidence within animal populations at 10 sites in each country. We will test 3 hypotheses to understand why H5N1 is able to persist endemically in these countries: (1) The pattern, size and distribution of poultry farms drives H5N1 endemism; (2) The pattern, frequency and intensity of contact networks among wild birds, domestic birds and people influences the risk of spillover and prolongs transmission; and (3) Integrating dynamical, network and spatial models across scales provides a strategy to better predict influenza-A transmission risk. This work will significantly advance our understanding of the long-term dynamics of H5N1 by using fine-scale measurements of realistic contact networks in epidemiological models of H5N1, allowing us to explain the poorly understood capacity of H5N1 to persist at low prevalence in endemic countries. Furthermore, the improved predictive models will aid in developing more effective control measures in these critical, high risk countries.
Public Health Relevance Statement
RELEVANCE (See instructions):
Projections for the next pandemic are as high as 142 million deaths and $4.4 trillion in economic losses. This
research will yield cost effective ways to identify high risk areas, helping to prioritize influenza surveillance
and control in order to detect outbreaks events quickly and prevent spread. It will also enhance the data and
methodologies available to the relevant ministries, and provided technical training, in the USA and abroad.
John E. Fogarty International Center for Advanced Study in the Health Sciences
CFDA Code
989
DUNS Number
UEI
077090066
TKS7NBB4JDN6
Project Start Date
17-September-2012
Project End Date
30-April-2014
Budget Start Date
17-September-2012
Budget End Date
30-April-2014
Project Funding Information for 2012
Total Funding
$300,000
Direct Costs
$260,240
Indirect Costs
$39,760
Year
Funding IC
FY Total Cost by IC
2012
John E. Fogarty International Center for Advanced Study in the Health Sciences
$300,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R56TW009502-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R56TW009502-01
Patents
No Patents information available for 1R56TW009502-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R56TW009502-01
Clinical Studies
No Clinical Studies information available for 1R56TW009502-01
News and More
Related News Releases
No news release information available for 1R56TW009502-01
History
No Historical information available for 1R56TW009502-01
Similar Projects
No Similar Projects information available for 1R56TW009502-01